arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

CRISPR Therapeutics AG

CRSP Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$49.99
▲ +0.2% Today
as of Oct 22, 16:47 ET
Last 30 days -5.61% Sep 14 → Oct 22
$48.47 $51.30 $54.14 $56.98 $59.81 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$50.01
High
$51.05
Low
$49.37
Volume
$905,807
Avg Vol
$2M
Mkt Cap
$5.4B
P/E (TTM)
—
Beta
—
52w High
$68.71
52w Low
$44.12
Div Yield
—
Shares Out
$97M

Recent Press Releases & News last 60 days · 25 items

Oct 21 · 12:30 Zacks
Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet
Oct 19 · 20:33 MT Newswires
CRISPR Therapeutics Names A.J. Silver as New Chief Financial Officer
Oct 19 · 20:05 PR GlobeNewswire
CRISPR Therapeutics Announces Chief Financial Officer Transition
▸ Show all 25 press releases & news Free account →

CRSP earnings at a glance

The options market is pricing a move of about ±3.3% after the report, a range of roughly $48.35 to $51.63 from today's $49.99. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±7.8% on average; after the most recent report on May 4, 2026 it moved +3.8%. That means options currently expect less movement than CRSP has typically delivered. CRSP beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 78%. The share price of $49.99 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$44
$69
24% of range
Avg surprise (last 4)
-3.3%
Avg reaction (last 2)
-4.0%
50% positive
Latest IV / EM
78%
EM ±3.3% · $50 · Oct 9

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.58$-1.35$-1.12$-0.90$-0.67 Actual $-0.67Actual $-0.98Actual $-1.41Actual $-1.43Actual $-1.49Actual $-1.01Actual $-1.58Est $-1.27Actual $-1.29Est $-1.47Actual $-1.17Est $-1.32Actual $-1.28Est $-1.14Actual $-0.94 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-209M$-154M$-99M$-44M$11M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.94 — — — — financials
Mon May 4, 2026Mar/2026 $-1.28 $-1.14 -12.3% +19.0% +3.8% earnings
Mon Nov 10, 2025Sep/2025 $-1.17 $-1.32 +11.4% — — earnings
Mon Aug 4, 2025Jun/2025 $-1.29 $-1.47 +12.2% — — earnings
Tue May 6, 2025Mar/2025 $-1.58 $-1.27 -24.4% — -11.9% earnings
Mon Sep 30, 2024Sep 2024 $-1.01 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.49 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.43 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.41 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.98 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.67 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$10M$1M—$889,000$892,000$865,000—$602,000
Cost of revenue————————
Gross profit————————
Operating income$-117M$-130M—$-132M$-229M$-148M—$-110M
Net income$-91M$-123M—$-106M$-209M$-136M—$-86M
EPS (diluted)$-0.94$-1.28—$-1.17$-2.40$-1.58—$-1.01

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$291M$423M$348M$286M$194M$235M$298M$226M
Inventory————————
Total current assets$2.37B$2.45B$1.99B$1.93B$1.73B$1.87B$1.94B$1.94B
Total assets$2.65B$2.73B$2.27B$2.25B$2.03B$2.17B$2.24B$2.26B
Long-term debt$586M$585M$0—————
Total liabilities$904M$911M$343M$329M$319M$337M$310M$316M
Total equity$1.75B$1.81B$1.92B$1.92B$1.71B$1.83B$1.93B$1.94B

Implied volatility — last 90 days

37%61%85%109%133% Jun 07 — IV 72% · EM ±6.7%Jun 08 — IV 70% · EM ±5.8%Jun 09 — IV 80% · EM ±5.8%Jun 10 — IV 98% · EM ±5.8%Jun 11 — IV 80% · EM ±3.3%Jun 15 — IV 70% · EM ±5.0%Jun 16 — IV 83% · EM ±4.9%Jun 17 — IV 103% · EM ±4.3%Jun 19 — IV 58% · EM ±6.4%Jun 22 — IV 64% · EM ±5.4%Jun 23 — IV 51% · EM ±3.7%Jun 24 — IV 70% · EM ±4.2%Jun 25 — IV 84% · EM ±3.5%Jun 29 — IV 62% · EM ±14.7%Jun 30 — IV 59% · EM ±13.8%Jul 01 — IV 81% · EM ±3.4%Jul 03 — IV 79% · EM ±8.7%Jul 06 — IV 82% · EM ±6.8%Jul 07 — IV 53% · EM ±3.8%Jul 08 — IV 104% · EM ±6.2%Jul 09 — IV 55% · EM ±2.3%Jul 13 — IV 87% · EM ±7.3%Jul 14 — IV 73% · EM ±5.3%Jul 15 — IV 82% · EM ±4.9%Jul 16 — IV 127% · EM ±5.3%Jul 20 — IV 63% · EM ±5.3%Jul 21 — IV 75% · EM ±5.4%Jul 22 — IV 59% · EM ±3.5%Jul 23 — IV 42% · EM ±1.8%Jul 27 — IV 80% · EM ±6.7%Jul 28 — IV 89% · EM ±6.4%Jul 29 — IV 85% · EM ±5.0%Jul 30 — IV 75% · EM ±3.1%Aug 03 — IV 109% · EM ±9.1%Aug 04 — IV 38% · EM ±2.7%Aug 05 — IV 69% · EM ±4.1%Aug 06 — IV 80% · EM ±3.4%Aug 10 — IV 64% · EM ±5.3%Aug 11 — IV 56% · EM ±4.0%Aug 12 — IV 55% · EM ±3.2%Aug 13 — IV 75% · EM ±3.1%Aug 18 — IV 55% · EM ±4.0%Aug 19 — IV 86% · EM ±5.1%Aug 20 — IV 93% · EM ±3.9%Aug 24 — IV 82% · EM ±6.9%Aug 25 — IV 56% · EM ±4.1%Aug 26 — IV 74% · EM ±4.4%Aug 27 — IV 117% · EM ±4.9%Aug 31 — IV 56% · EM ±4.7%Sep 01 — IV 95% · EM ±6.9%Sep 02 — IV 58% · EM ±3.4%Sep 03 — IV 134% · EM ±5.6%Sep 07 — IV 54% · EM ±4.5%Sep 08 — IV 81% · EM ±5.8%Sep 09 — IV 87% · EM ±5.2%Sep 10 — IV 73% · EM ±3.1%Sep 14 — IV 66% · EM ±5.5%Sep 15 — IV 69% · EM ±5.0%Sep 16 — IV 79% · EM ±4.7%Sep 17 — IV 106% · EM ±4.4%Sep 21 — IV 63% · EM ±5.2%Sep 22 — IV 71% · EM ±5.1%Sep 23 — IV 88% · EM ±5.2%Sep 24 — IV 65% · EM ±2.7%Sep 28 — IV 55% · EM ±13.0%Sep 29 — IV 62% · EM ±14.5%Sep 30 — IV 79% · EM ±4.7%Oct 01 — IV 119% · EM ±5.0%Oct 05 — IV 74% · EM ±6.2%Oct 06 — IV 74% · EM ±5.4%Oct 07 — IV 86% · EM ±5.1%Oct 08 — IV 78% · EM ±3.3%

Sector peers

SRRK
Scholar Rock Holding Corporation
$5.6B $41.96+1.4%
IOVA
Iovance Biotherapeutics, Inc.
$5.9B $14.14-4.8%
CGON
CG Oncology, Inc.
$6.1B $62.54+1.0%
KOD
Kodiak Sciences Inc
$6.2B $85.78-7.7%
ADPT
Adaptive Biotechnologies Corporation
$4.2B $24.41-0.0%
RLAY
Relay Therapeutics, Inc.
$3.9B $18.34-0.6%

CRSP earnings FAQ

What is CRSP's expected move for earnings?

Options currently price a move of about ±3.3%, or $1.64 per share either way from $49.99.

How does CRSP stock usually react to earnings?

Across the last 2 reports the average next-day move was ±7.8%, up 1 times and down 1 times.

What is CRSP's implied volatility?

CRSP's at-the-money implied volatility is about 78% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in